InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Jenkins John Kenneth. Officer active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. Aggregated, 2 filings have been logged. Activity tracked since 30 May 2024. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations